Adjei, Akwete L. http://orcid.org/0000-0001-5772-7866
Chaudhary, Inder
Kollins, Scott H.
Padilla, Americo
Clinical trials referenced in this document:
Documents that mention this clinical trial
A Pharmacokinetic Study of Methylphenidate Hydrochloride Multilayer Extended-Release Capsules (Aptensio XR®) in Preschool-Aged Children with Attention-Deficit/Hyperactivity Disorder
https://doi.org/10.1007/s40272-020-00409-z
Funding for this research was provided by:
Rhodes Pharmaceuticals, L.P.
Article History
First Online: 10 August 2020
Declarations
:
: This study was funded by Rhodes Pharmaceuticals L.P.
: Akwete L. Adjei and Inder Chaudhary are employees of Rhodes Pharmaceuticals L.P. Scott H. Kollins receives research support and/or consulting fees from Aevi Genomic Medicine, Akili, Alcobra, Bose, Ironshore, Jazz, KemPharm, NLS, Purdue Canada, Rhodes Pharmaceuticals L.P., Shire, SK Life Science, and Sunovion. Americo Padilla has nothing to disclose.
: The study was undertaken in compliance with the Good Clinical Practice Guidelines of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use and the principles of the Declaration of Helsinki. The protocol (WIRB No. 20150806) was reviewed and approved by the Western Institutional Review Board<sup>®</sup> (Puyallup, WA, USA).
: All participants/guardians provided consent to participate in the study.
: Not applicable.
: Raw data presented in this analysis are available by request atExternalRef removed.
: Not applicable.
: Analyses were conducted by Inder Chaudhary and data interpretation was provided by all authors. Akwete L. Adjei wrote the first draft and all authors provided input into revising the article and approved the final version for publication.